BioXcel Therapeutics, Inc. (BTAI)
1.55
-0.02
(-1.27%)
USD |
NASDAQ |
Mar 12, 16:00
1.56
+0.01
(+0.65%)
After-Hours: 05:50
BioXcel Therapeutics Market Cap : 33.90M for March 12, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Rigel Pharmaceuticals, Inc. | 491.38M |
| Puma Biotechnology, Inc. | 299.15M |
| Quince Therapeutics, Inc. | 5.930M |
| ACADIA Pharmaceuticals, Inc. | 3.626B |
| Alnylam Pharmaceuticals, Inc. | 42.07B |
Market Cap Related Metrics
| PS Ratio | 15.41 |
| PEG Ratio | -0.0005 |
| Price | 1.55 |
| Earnings Yield | -625.7% |
| PEGY Ratio | -0.0005 |